Iron-induced virulence of Salmonella enterica serovar typhimurium at the intestinal epithelial interface can be suppressed by carvacrol by Kortman, G.A.M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/138357
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Iron-Induced Virulence of Salmonella enterica Serovar Typhimurium
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Oral iron therapy can increase the abundance of bacterial pathogens, e.g., Salmonella spp., in the large intestine of African chil-
dren. Carvacrol is a natural compound with antimicrobial activity against various intestinal bacterial pathogens, among which is
the highly prevalent Salmonella enterica serovar Typhimurium. This study aimed to explore a presumed interaction between
carvacrol and bacterial iron handling and to assess the potential of carvacrol in preventing the increase of bacterial pathogenicity
during high iron availability. S. Typhimuriumwas cultured with increasing concentrations of iron and carvacrol to study the
effects of these combined interventions on growth, adhesion to intestinal epithelial cells, and iron uptake/influx in both bacterial
and epithelial cells. In addition, the ability of carvacrol to remove iron from the high-affinity ligand transferrin and an Fe-dye
complex was examined. Carvacrol retarded growth of S. Typhimurium at all iron conditions. Furthermore, iron-induced epithe-
lial adhesion was effectively reduced by carvacrol at high iron concentrations. The reduction of growth and virulence by carva-
crol was not paralleled by a change in iron uptake or influx into S. Typhimurium. In contrast, bioavailability of iron for epithe-
lial cells was moderately decreased under these conditions. Further, carvacrol was shown to lack the properties of an iron
binding molecule; however, it was able to weaken iron-ligand interactions by which it may possibly interfere with bacterial viru-
lence. In conclusion, our in vitro data suggest that carvacrol has the potential to serve as a novel dietary supplement to prevent
pathogenic overgrowth and colonization in the large intestine during oral iron therapy.
Salmonella enterica serovar Typhimurium is a major cause ofgastroenteritis and invasive disease in humans, particularly in
susceptible children in tropical Africa (1). Concurrently, there is a
high prevalence of iron deficiency among children in developing
countries. These children require oral iron therapy to prevent de-
velopmental impairment (2). Precariously, growth and coloniza-
tion of S. Typhimurium appear to be stimulated by increased lu-
minal iron availability in vitro, as well as in vivo, in several but not
all published studies (3–6). Thus, there is an unfulfilled need to
suppress this common intestinal pathogen.
Carvacrol is a monoterpenoid phenol present in essential oils;
it has antimicrobial activity and is one of the main components in
oregano and thyme oil (7). It has been shown to be active against
various intestinal pathogens, including S. Typhimurium (7). Car-
vacrol appears to target the outer membrane of Gram-negative
bacteria and increases membrane permeability, thereby causing
depletion of the cellular ATP pool and leakage of other cytoplas-
mic constituents and outer membrane-associated material (7, 8).
However, this process is currently not fully understood, and ad-
ditionalmodes of actionmight exist. It has previously been shown
that subinhibitory concentrations of carvacrol can affect virulence
traits as it slightly reduced adhesion of S. Typhimurium to intes-
tinal epithelial cells and significantly reduced invasion into these
cells (9). In contrast, it was shown that increased iron availability
promoted S. Typhimurium adhesion to, and invasion into, intes-
tinal epithelial cells (3). Further, carvacrol was shown to increase
expression of the heat shock protein GroEL and inhibit the syn-
thesis of flagellin in Escherichia coli O157:H7 when grown in a
standard rich medium (10). On the other hand, moderate to high
iron availability reduced GroEL expression and increased flagellin
synthesis in S. Typhimurium compared to low iron availability
(G. A. M. Kortman, R.W. H.M. Roelofs, and H. Tjalsma, unpub-
lished data). The above-describedfindings inspired us to speculate
that carvacrol may exert (in part) its antimicrobial mode of action
through interference with pathways for bacterial iron handling.
The present study aimed to investigate this hypothesis and to ex-
plore, by an in vitro approach, the potential of carvacrol to serve as
a food additive to prevent pathogenic overgrowth and coloniza-
tion in the large intestine during oral iron therapy.
MATERIALS AND METHODS
Bacterial strain, media, and growth conditions. The strain used in this
study was Salmonella Typhimurium NTB6 (3). This bacterium was cul-
tured at 37°C and 5% CO2 (standard conditions) in Iscove’s modified
Dulbecco’s medium (IMDM; Invitrogen). This chemically defined me-
dium does not contain iron in its formulation.
Growth curves and determination of the MIC. To determine the ef-
fects of iron and carvacrol on growth of S. Typhimurium, IMDMmedium
with increasing ferric citrate (Sigma-Aldrich) and carvacrol (Sigma-Al-
drich) concentrations was inoculated with a fresh bacterial culture after
overnight growth. A stock solution of ferric citrate was made in Milli-Q
water (MQ), and a 0.1 mol/liter stock of carvacrol was made in absolute
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ethanol. Final concentrations of ethanol were kept constant at 2.5% (vol/
vol) for each condition. Portions of 200 l of culture medium were inoc-
ulated in a microplate (in duplicate) and incubated statically at 37°C
within a plate reader. Tomonitor bacterial growth, the optical density was
automatically measured at 620 nm (OD620) every 20 min.
To determine the lowest concentration of carvacrol that inhibits the
visible growth of S. Typhimurium NTB6 in IMDM, a serial dilution of
carvacrol (0, 0.75, 1.0, 1.25, 1.5, 1.75, 2.0, and 2.5mmol/liter) in IMDM in
the presence of 0, 1, 10, or 100 mol/liter ferric citrate was tested. A total
of 2 ml of medium in sterile, 75- by 12-mm capped tubes was inoculated
with a fresh bacterial culture, and the OD620 was assessed after overnight
incubation at 37°C. A negative control containing no bacteria was in-
cluded. The MIC value, for the specific incubation conditions applied in
the present study, was defined as the lowest concentration where no
increase in optical density was observed, and concentrations of carva-
crol below the MIC (and above 0 mmol/liter) that still supported
growth were defined as subinhibitory. It should be noted that we chose
to determine the MIC values for the growth medium that was used in
this study to sustain consistent growth conditions. If desired in future
studies, the MIC should be determined in a more standard reference
growth medium (see, e.g., CLSI [http://www.clsi.org/standards/] or
EUCAST [http://www.eucast.org/antimicrobial_susceptibility_testing/mic
_determination] recommendations).
Cell line, media, and growth conditions. The human colorectal ade-
nocarcinoma cell line Caco-2 (obtained from the American Type Culture
Collection) was cultured at standard conditions in Dulbecco’s modified
Eagle’s medium (DMEM; Lonza) supplemented with 10% heat-inacti-
vated fetal bovine serum (FBS; Invitrogen), 20 mmol/liter HEPES, 100
nmol/liter nonessential amino acids (Invitrogen), and 2mmol/liter L-glu-
tamine (Lonza). Cells were subcultured every 6 days and used between
passage numbers 3 and 6.
Bacterial adhesion assay. The influence of iron and carvacrol on ad-
hesion of S. Typhimurium to Caco-2 cells was studied by the use of the
following adhesion assay.
(i) Preincubation of bacteria with ferric citrate and carvacrol.
IMDM with increasing ferric citrate concentrations (0 to 50 mol/liter)
and carvacrol concentrations (0 to 0.5 mmol/liter) was inoculated with S.
Typhimurium (overnight culture) and grown to exponential phase. The
bacterial cells were pelleted, resuspended, and concentrated in IMDM
with 10% glycerol for storage at 80°C until use. Serial dilutions of
thawed stocks were transferred to blood agar plates and incubated over-
night to determine the CFU.
(ii) Culturing of Caco-2 cells. Caco-2 cells were subcultured in a 24-
well plate and maintained until use in adhesion assays. The assays were
performed on confluentmonolayers between 14 and 16 days after seeding
the cells.
(iii) Bacterial adhesion assay. The Caco-2 monolayers were washed
once with phosphate-buffered saline (PBS). The preincubated stocks of S.
Typhimurium were pelleted and resuspended in IMDM. Next, bacteria
were added to the monolayers at a multiplicity of infection (MOI) of 10:1
in IMDM followed by incubation for 2 h at standard conditions. To de-
termine the number of adherent bacteria, monolayers were washed three
times with PBS, and cells were trypsinized and lysed with ice-cold PBS
containing 0.025%TritonX-100. Serial dilutions of cell lysateswere trans-
ferred to blood agar plates for CFU counting.
Determination of iron uptake by S. Typhimurium under the influ-
ence of carvacrol. To determine the effect of carvacrol on iron uptake by
S. Typhimurium, bacterial cells were grown with iron and carvacrol, after
which the total iron content of the bacteria was determined. Cultures (10
ml) of S. Typhimurium were incubated with ferric citrate (0 to 50 mol/
liter) and carvacrol (0 to 0.5 mmol/liter) under standard conditions. Bac-
teria were harvested by centrifugation for 5 min at 3,220 g, and pellets
were resuspended in 5 ml PBS containing 1 mmol/liter deferoxamine
(DFO; Sigma-Aldrich) to sequester iron that is loosely bound to the outer
membrane of the bacteria. After another centrifugation step, pellets were
resuspended in 1.5ml PBS and transferred to fresh 2-ml tubes. Tubeswere
centrifuged for 5 min at 10,000  g, and the supernatant was removed.
Pellets were snap-frozen in liquid nitrogen (3), wet pellet weight was
noted, and iron content was determined by acid digestion of the bacteria
and use of the chromogen bathophenanthroline as described by Torrance
and Bothwell (11). To this purpose, bacterial pellets were resuspended in
80 l of acid reagent (3 mol/liter HCl containing 10% trichloroacetic
acid) and incubated at 65°C for 20 h with continuous mixing. After incu-
bation, samples were centrifuged to obtain the supernatant, and 20l was
applied to a microplate. Then, 200 l chromogenic reagent containing
127 mg/liter bathophenanthroline sulfonate disodium salt (Fluka), 936
mg/liter thioglycolic acid sodium salt (Sigma-Aldrich), and sodium ace-
tate (diluted 2.2 times from a saturated solution) was added to the sam-
ples. After 10 min of incubation at room temperature (RT), color forma-
tion was measured at 540 to 560 nm. Iron concentration was determined
by comparison to a standard curve made of ferrous sulfate and was cor-
rected for wet pellet weight.
Determination of iron bioavailability to Caco-2 cells. To examine
the effect of carvacrol on the uptake of iron by enterocytes, Caco-2 cells
were exposed to iron and carvacrol. Iron uptake was quantified by mea-
surement of intracellular ferritin levels.
(i) Culturing of Caco-2 cells. Culturing was done as described above,
with the exception that the assays were performed between 13 and 14 days
after seeding the cells.
(ii) Exposure of Caco-2 cells to iron and carvacrol. Two days before
incubation of the cells with iron and carvacrol, the standard culture me-
dium was replaced by IMDM. Both ferric citrate and ferrous sulfate (20
mol/liter Fe) in combination with carvacrol (0 to 0.3 mmol/liter) or
ascorbic acid (200 mol/liter) and tannic acid (2 mol/liter) as the posi-
tive and negative control, respectively, were applied to the cells in fresh
IMDM.Higher concentrations of carvacrol could not be tested, because of
cytotoxic effects to the cells. The cells were incubated for 20 h at standard
conditions. At harvesting, cells were washed once with 1 ml PBS contain-
ing 1 mmol/liter DFO and washed once with 1 ml PBS. Cells were frozen
on dry ice and thawed, after which 100 l of 5 mmol/liter NaOH was
added. Cells were then lysed by sonication for 15min in a sonication bath
containing icewater. To neutralize, 50l of 10mmol/literHClwas added,
and cells were loosened by scraping. Suspensions were sonicated 5
min and then transferred to fresh tubes. Debris was pelleted by centrifu-
gation, and the supernatant was used for quantification of total protein
and ferritin.
(iii) Quantification of ferritin levels. Samples were applied to the
ferritin enzyme-linked immunosorbent assay (ELISA; Spectro ferritin;
Ramco), and the assay was performed according to the manufacturer’s
instructions. Ferritin levels were normalized for total protein content.
Total protein was measured by the use of a Bradford protein assay (Bio-
Rad) according to the manufacturer’s instructions.
Iron removal from transferrin assay. To examine the potential of
carvacrol to sequester iron, the ability of carvacrol to remove iron from
transferrin was investigated. Incubation buffer containing 100mmol/liter
Tris-HCl (pH7.5) and 10%glycerol (vol/vol)was depleted of trace iron by
pretreatment with Chelex-100 resin (Sigma-Aldrich). Then, 50 g of
holo-transferrin (hTf) from human (Sigma-Aldrich) was dissolved in 50
l incubation buffer, and hTf was incubated with carvacrol (0 to 250
mol/liter) and positive controls DFO (500 mol/liter) and tannic acid
(Sigma-Aldrich; 100 mol/liter) for 18 h at 37°C. The iron binding status
of transferrin (Tf) was investigated by polyacrylamide gel electrophoresis
according to the method described by Makey and Seal (12) with a few
adaptations. Briefly, a freshly prepared solution containing 6% acryl-
amide (37.5:1 with bis-acrylamide), 6 mol/liter urea, and TBE buffer (0.1
mol/liter Tris, 0.01 mol/liter boric acid, 0.05 mol/liter EDTA, pH 8.4) was
pretreated with Chelex-100 resin and then polymerized in a Bio-Rad Pro-
tean II vertical minigel system. The gel was prerun at 70 V for 20min, and
20g of the Tf samples was loaded. Partially saturated human transferrin
(Sigma-Aldrich) was used as a marker standard (20 g). The gel tray was
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placed in ice water, and electrophoresis was performed at 100 V for 7 h.
After electrophoresis, the gel was fixed for 15 min in fixative containing
10% (vol/vol) acetic acid, 50% (vol/vol) methanol, and 40% demineral-
ized water (vol/vol). To visualize forms of Tf, it was stained with Coomas-
sie brilliant blue.
Iron removal from CAS assay. A universal chemical assay for the
detection of iron acquisition siderophores was used to examine the capa-
bility of carvacrol to remove iron from a dye-Fe complex. Chrome azurol
S (CAS) in complex with ferric iron and hexadecyltrimethylammonium
bromide (HDTMA) has a blue color but turns orange when iron is re-
moved from the dye by a stronger ligand. Themethod used was originally
described by Schwyn andNeilands (13). Briefly, a solution of 2mmol/liter
CAS (Tokyo Chemical Industry) was prepared, and 1,875 l was mixed
with 375 l ferric iron solution (1 mmol/liter FeCl3 [Merck] in 10 mmol/
liter HCl). Separately, 1.5 ml of 10 mmol/liter HDTMA (Sigma-Aldrich)
was placed in an acid-cleaned volumetric flask of 25ml, and the CAS-iron
mixture was slowly added with simultaneous mixing. Then, 1.077 g of
anhydrous piperazine (Fluka) was dissolved in 7 ml MQ, and 1,560 l of
12 mol/liter HCl was added. This buffer was rinsed into the volumetric
flask, and MQ was added to 25 ml to complete the assay solution. The
solution was stored in a plastic tube in the dark. To establish increased
speed in iron exchange, a shuttle solution was prepared which involved
the addition of 25.42 mg 5-sulfosycilic acid dihydrate (Sigma-Aldrich) to
the assay solution before adding the final MQ to a total of 25 ml.
Iron removal capacity and speed of iron removal were tested in a
microplate. A total of 100 l carvacrol (0 to 1 mmol/liter in IMDM or
MQ), DFO (0 to 20 mol/liter in IMDM orMQ), or tannic acid (0 to 5.9
mol/liter in IMDM or MQ) was mixed with 100 l CAS assay (shuttle)
solution. Absorption was periodically monitored at 620 nm.
Statistical analysis. To compare means, an unpaired t test (2-tailed)
was used. In case of unequal variances (as assessed by F-test), an unpaired
t test withWelch’s correction was carried out. To assess the slope of iron-
dependent adhesion, linear regression analysis was applied. For compar-
ison of iron uptake by S. Typhimurium under influence of carvacrol,
two-way analysis of variance (ANOVA) was performed. All analyses were
performed using GraphPad Prism version 5.00 for Windows, GraphPad
Software, San Diego, CA. P values of 0.05 were considered statistically
significant.
RESULTS
Growth of S. Typhimurium in response to iron and carvacrol.
To evaluate the possibility that the antimicrobial effect of carva-
crol can be explained by its interference with bacterial iron han-
dling, the effect of carvacrol on growth of S. Typhimurium was
tested under moderate iron concentrations and iron-rich condi-
tions. In general, these experiments showed that carvacrol can
delay the onset of growth of this bacterium. Growth delay was
established under both moderate iron concentrations and high-
iron conditions (Fig. 1A; see also Fig. S1 in the supplemental ma-
terial). In the absence of carvacrol, the high-iron conditions
were not influencing growth compared to the moderate iron
concentrations. However, in the presence of carvacrol, a
shorter lag phase is observed with culture medium containing
high iron concentrations than growthwithmoderate iron concen-
trations. This suggests that high iron availability partly compen-
sates the postponement effect of carvacrol. Notably, increased car-
vacrol concentration of 1 mmol/liter strongly retarded growth,
but growth was strikingly less retarded in 50 to 100 mol/liter
ferric citrate compared to 1 to 10mol/liter ferric citrate (Fig. 1B).
Levels of carvacrol of1 mmol/liter were found to be the subin-
hibitory range under these conditions, as 1 mmol/liter carvacrol
was the highest concentration tested that still supported growth
under all iron conditions. A slightly higher concentration of 1.25
mmol/liter effectively prevented an increase in optical density af-
ter overnight growth (MIC).
AdhesionofS. Typhimuriumtoanepithelialmonolayer.Ad-
hesion to host epithelial cells is an important virulence character-
istic for pathogenic bacteria. To test whether iron-induced adhe-
sion, as observed previously (3), can be counteracted by carvacrol,
S. Typhimurium was first preincubated with increasing concen-
trations of ferric citrate and carvacrol. To determine the adhesion,
preincubated bacteria were added to intestinal epithelial mono-
layers (Caco-2) under iron-limiting conditions and without car-
vacrol. Adhesion was expressed as the percentage of the bacterial
inoculum and relative to the conditions without iron addition
during preincubation. As shown in Fig. 2, iron stimulated the
adhesion of S. Typhimurium; however, this effectwas significantly
reduced by carvacrol, especially at the highest iron concentration
tested. It should be noted that carvacrol did not significantly affect
adhesion under the condition without iron (see Fig. S2 in the
supplemental material). Linear regression analysis revealed that
the slope of the control conditionswithout carvacrol (2.79 0.50)
was significantly steeper than the slope of the 0.2 mmol/liter car-
vacrol conditions (0.51  0.20) (P  0.013). Slope of the condi-
tions with 0.5 mmol/liter carvacrol (1.47 0.48) was lower than
the controls, although not significantly (P  0.129). Taken to-
gether, these experiments show that subinhibitory levels of carva-
crol can reduce iron-induced adhesion of S. Typhimurium to an
epithelial monolayer.
FIG 1 Effect of iron and subinhibitory concentrations of carvacrol on growth
of S. Typhimurium. (A) Effect of 0.6 mmol/liter carvacrol (CV) on S. Typhi-
murium growth (mean  range) for 8 h in medium with 1 mol/liter (open
circles) or 100 mol/liter ferric citrate (FeC) (open squares) compared to the
same conditions without carvacrol (filled circles or squares, respectively) (n
2; duplicate wells). (B) Effect of 1 mmol/liter carvacrol on growth of S. Typhi-
murium for 13.3 h with 100 (open squares), 50 (open circles), 10 (filled
squares), or 1 (filled circles)mol/liter ferric citrate (n 2).Without addition
of any iron, growth is more hampered, as the trace amount of iron in the
IMDM limits growth of S. Typhimurium (3).
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Iron uptake by S. Typhimurium under influence of carva-
crol. One of the mechanisms by which carvacrol could influence
bacterial adhesion is the inhibition of iron uptake by S. Typhimu-
rium, which consequently would affect adhesion traits. To inves-
tigate this, we measured total iron content of S. Typhimurium
cells which were grown in the presence of increasing concentra-
tions of ferric citrate and carvacrol. The iron content of the bac-
teria grownwithout carvacrol was significantly increased in the 10
mol/liter ferric citrate condition compared to that in the 1mol/
liter ferric citrate condition (P 0.012) and further increasedwith
50 mol/liter ferric citrate (P  0.034 compared to 1 mol/liter
ferric citrate), indicating increased iron uptake at increasing iron
concentration as expected (Fig. 3). Carvacrol appeared not to in-
fluence iron uptake or influx significantly at all iron concentra-
tions tested (two-way ANOVA). As carvacrol did not reduce the
uptake of iron by S. Typhimurium, the inhibiting effect on adhe-
sion can probably not be explained by altered iron uptake.
Bioavailability of iron to intestinal epithelial cells under in-
fluence of carvacrol. To examine the effect of carvacrol on intes-
tinal iron uptake in vitro, iron together with nontoxic concentra-
tions of carvacrol were applied to Caco-2 monolayers. Next to
ferric citrate, ferrous sulfate was tested, as this form of iron is
widely used in iron supplementation studies. Cytoplasmic levels
of ferritin were used as a measure for cellular iron uptake. As
shown in Fig. 4, in the absence of carvacrol, bioavailability of ferric
citrate was higher than ferrous sulfate (P 0.004). Bioavailability
of both iron sources was considerably reduced by carvacrol; ferri-
tin formation was about 2.5 times less with 0.3 mmol/liter carva-
crol compared to that of the no-carvacrol controls (P 0.0002 for
both iron sources).Notably, carvacrol did not abolish iron uptake,
while the addition of the food derived and strong iron binding
tannic acid at 2 mol/liter resulted in a near-complete block of
iron uptake (see Fig. S3A in the supplemental material). We note
that higher concentrations of carvacrol could not be tested due to
toxic effects to the cells, as determined by a lactate dehydrogenase
(LDH) release assay (see Fig. S4 in the supplemental material). In
contrast, 200 mol/liter ascorbic acid as a known promoter of
iron uptake enhanced iron uptake of both iron sources, especially
of ferric citrate (P 0.003 and P 0.0001 for ferrous sulfate and
ferric citrate, respectively) (see Fig. S3B in the supplemental ma-
terial).
Ironbinding capacity of carvacrol.Thepotential iron binding
capacity of carvacrol, or its ability to dissociate iron from iron
binding ligands, was investigated in an iron from transferrin re-
moval assay and a universal siderophore CAS assay. The iron from
the transferrin removal assay revealed that carvacrol up to 0.25
mmol/liter could not take away iron from transferrin, indicating
that carvacrol is not a high-affinity iron binding molecule and
cannot dissociate the transferrin-iron complex (Fig. 5). In con-
trast, use of the strong iron binding molecules DFO and tannic
acid, which served as positive controls in this assay, clearly showed
their ability to remove 1 or 2 iron atoms from the transferrin
molecule.
As shown in Fig. 6A, the siderophore CAS assay revealed that
carvacrol can dissociate the Fe-dye complex partly (0.2 mmol/
liter) or completely (0.6 mmol/liter); however, this was observed
only after a long incubation of 15 h, while dissociation of the
Fe-dye complex was already evident after only 3 h for the positive
controls DFO (Fig. 6B) and tannic acid (not shown) at low con-
centrations. CAS-shuttle solution increased the transfer speed of
Fe from the dye toDFO, but thiswas not true for carvacrol (Fig. 6A
and B). Together, these results indicate that carvacrol does not
FIG 2 Effect of carvacrol on iron-induced adhesion of S. Typhimurium to an
epithelial monolayer. Adhesion (mean SD) of S. Typhimurium to a mono-
layer of Caco-2 cells is given as the percentage of the inoculum and expressed
relative to the conditions without iron during preincubation. Data consists of
3 separate experiments in which adherent CFU were determined on different
days with duplicate wells (n 6). *, P 0.05; ***, P 0.001.
FIG 3 Total iron content of S. Typhimurium after growth with iron and
carvacrol. S. Typhimurium was grown to mid-log phase with increasing con-
centrations of iron and carvacrol. Iron content (mean  range) is given as
ng/mg wet biomass (n  2). Means without a common letter differ signifi-
cantly (P 0.05).
FIG 4 Influence of carvacrol on the bioavailability of iron to an epithelial
monolayer. Caco-2 cells were exposed to equimolar concentrations of iron and
increasing concentrations of carvacrol. Bioavailability of iron is expressed as
total intracellular ferritin content, corrected for total protein (mean  SD).
Data consist of 2 separate experiments with measurements performed in trip-
licate (n 6). Means without a common letter differ significantly (P 0.05).
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bind iron strongly, but it may be able to disturb iron-ligand com-
plexes under certain conditions.
S. Typhimurium global lipopolysaccharide (LPS) composi-
tion during growth with iron and carvacrol.As LPS is an impor-
tant factor in bacterial adhesion (14, 15) and carvacrol is known to
induce the release of LPS fromE. coliO157:H7 (8), carvacrol could
affect adhesion characteristics of S. Typhimurium by removing
LPS from the cell surface. We therefore examined the effect of
carvacrol on LPS content and global LPS composition during
growth under moderate- to high-iron conditions. As shown in
Fig. S5 in the supplemental material, carvacrol up to 0.5 mmol/
liter did not detectably influence LPS quantity or global LPS com-
position. It should be noted that this general analysis cannot visu-
alize LPS in great detail and indicates only that carvacrol did not
alter global LPS status of S. Typhimurium during growth, which
makes it less likely that iron-induced adhesion was reduced by
modulating LPS integrity at the bacterial surface.
DISCUSSION
Oral iron supplementation has potential harmful side effects on
gastrointestinal health as a consequence of increased colonization
and growth of bacterial pathogens (3, 4). As a result, there is a
demand for safer iron supplementation programs. Therefore, we
here assessed by an in vitro approach whether the simultaneous
addition of carvacrol as an antimicrobial agent could counteract
the potential adverse effect of iron on the prevalent intestinal
pathogen S. Typhimurium.
In the present study, we showed that subinhibitory concentra-
tions of carvacrol retarded bacterial growth under all tested con-
ditions. Notwithstanding the presence of a sufficient amount of
iron under all conditions, the growth retardation effect of carva-
crol was most pronounced under conditions of moderate iron
availability. This suggested that its antimicrobial activity is partly
related to an iron scavenging effect that is less effectual under
high-iron conditions. Nevertheless, we want to emphasize that
subinhibitory concentrations of carvacrol delayed growth of S.
Typhimurium under all conditions. Hence, the previously de-
scribed antimicrobial activity of carvacrol also applies for condi-
tions with high iron availability (7). Although the ability to repli-
cate is important for bacterial pathogens, the adhesion to host
tissues or epithelium is pivotal to establish an infection. Our cur-
rent data confirm previous findings that iron induces adhesion of
S. Typhimurium to intestinal epithelial cells in vitro (3). Impor-
tantly, preincubation of S. Typhimuriumwith subinhibitory con-
centrations of carvacrol clearly reduced adhesion induced by
moderate to high iron concentrations. Together, these observa-
tions support the use of carvacrol as a potential additive in oral
iron preparations to prevent pathogenic overgrowth and coloni-
zation during iron supplementation.
An antimicrobial additive in an iron preparation should not
decrease iron uptake from the intestinal lumen or, ideally, should
increase it. We therefore investigated the effect of carvacrol on the
uptake of iron from different sources by intestinal epithelial
Caco-2 cells. Expression of ferritin was used as a readout, which is
commonly used as a gold standard to study bioavailability of iron
preparations (16). Although carvacrol clearly restricted iron up-
take of both ferrous sulfate and ferric citrate, it did not block iron
uptake completely like tannic acid, a well-known iron binder, did
(17). In general, the bioavailability of ferrous iron is better than
that of ferric iron (18–20), but with ferric citrate larger amounts of
ferritin weremeasured thanwith ferrous sulfate, indicating that in
this system the bioavailability of ferric citrate is better. The higher
solubility and stability of ferric citrate than those of ferrous sulfate
are probably the reasons for this observation. Thus, carvacrol
seemsnot tomeet the ideal criteria of an iron additive, as it impairs
iron uptake by intestinal cells in vitro. Nevertheless, this decreased
level of iron bioavailability could still suffice for adequate iron
uptake and healthy iron homeostasis in vivo, whereas it may be
FIG 5 Iron from transferrin removal assay. hTf was incubated with increasing
concentrations of carvacrol and the positive controls DFO and tannic acid
(TA) to assess iron removal from hTf. First lane, partially saturated Tf; second
lane, hTf control; third lane, 500 mol/liter DFO; fourth lane, 0 mol/liter
carvacrol (CV) solvent control; fifth lane, 1mol/literCV; sixth lane, 10mol/
liter CV; seventh lane, 100 mol/liter CV; eighth lane, 250 mol/liter CV;
ninth lane, 100 mol/liter TA. Top arrow indicates Tf without iron bound to
it, middle arrow indicates Tf with 1 Fe atom bound, and bottom arrow indi-
cates hTf with 2 Fe atoms bound to the protein.
FIG 6 Effect of carvacrol on the stability of the CAS-Fe complex. Removal of
iron from the colored complex is displayed as a decrease in optical density.
Carvacrol or DFO was incubated with the CAS-Fe complex without and with
shuttle solution (filled and open symbols, respectively). (A)Dissociation of the
Fe-dye complex in time was monitored without the addition of carvacrol
(filled circles) andwith the addition of 0.2mmol/liter (filled and open squares)
or 0.6 mmol/liter carvacrol (filled and open triangles). (B) As control condi-
tions, the CAS-Fe complex was incubated without DFO (filled and open cir-
cles) and with the addition of 20 mol/liter DFO (filled and open triangles).
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accompanied by a desirable decrease in virulence of pathogenic
gut bacteria.
Iron scavenging by carvacrol could have explained the growth
delay and decreased adhesion of S. Typhimuriumundermoderate
iron concentrations and the decreased bioavailability of iron to
Caco-2 cells in the presence of carvacrol. However, based on the
molecular structure of carvacrol, it seems unlikely that it can bind
iron ions. Additionally, in the present study, we showed that car-
vacrol could not remove iron from the high-affinity protein trans-
ferrin but was able to dissociate a dye-Fe complex during pro-
longed incubations. Together, this indicates that carvacrol seems
not to bind iron directly but is able to disturb iron-ligand com-
plexes with lower affinity. It can therefore be envisaged that car-
vacrol may interfere with iron uptake pathways of intestinal epi-
thelial cells rather thanmaking it less bioavailable by scavenging of
iron ions. However, it remains to be elucidated by which molec-
ular mechanisms carvacrol could affect cellular iron uptake sys-
tems. In contrast to the reduced ironuptake by intestinal epithelial
cells, we were not able to show a significant effect of carvacrol on
iron uptake or influx into S. Typhimurium. Consequently, the
observed effects of subinhibitory concentrations of carvacrol on
iron-induced growth and adhesion can probably not be explained
by interference with bacterial iron uptake or increased influx but
instead seem predominantly caused by other (iron-independent)
activities of carvacrol.
Although total iron content of S. Typhimuriumwas not altered
by carvacrol, the free intracellular iron pool balance could be dis-
torted. A potential elevation of the intracellular “free” iron pool
may enhance cell stress via generation of oxygen radicals (Fenton
chemistry). This increased iron toxicity may contribute to an
overall reduced fitness of the bacteria, which could very well result
in the observed adhesion defects under iron-replete conditions in
the presence of carvacrol. If true, it remains difficult to explain
why S. Typhimurium grows slightly better in mediumwith carva-
crol andhigh iron concentrations but adheres lesswell under these
conditions than bacteria grown under intermediate iron concen-
trations with carvacrol. Another possible explanation for the car-
vacrol-induced delay in growth and decreased adhesion of S. Ty-
phimurium involves a decrease in outer membrane integrity/
stability or an altered surface structure. Carvacrol is known to
induce release of LPS from E. coli O157:H7 (8). Similarly, iron
depletion is associated with reduced LPS content in Helicobacter
pylori (21). As LPS is a known modulator of bacterial adhesion,
both iron concentration and the addition of carvacrol could there-
fore theoretically affect S. Typhimurium adhesion. However, the
outcome of our first LPS characterization experiments did not
show a clear alteration of LPS content or structure when S. Typhi-
murium was grown in the presence of iron and carvacrol. Never-
theless, carvacrol and high concentrations of iron could still de-
stabilize the bacterial outer membrane through interference with
divalent cations such as Mg2 and Ca2 that bind to the anionic
LPS and thereby stabilize the outermembrane (22). Carvacrol and
iron could somehow distort this delicate balance and thereby in-
directly influence LPS-mediated adhesion. To assess this hypoth-
esis, the potential interaction of iron and carvacrol with LPS needs
to be investigated further in greater detail. This could involve the
detection and characterization of LPS shed into the medium by
using additional LPS characterization techniques.
In summary, the natural antimicrobial carvacrol can poten-
tially be used as an additive during oral iron therapy to prevent
pathogenic overgrowth and colonization in the large intestine.
Future in vivo research should reveal whether carvacrol can indeed
improve the safety of oral iron therapy. The success of this ap-
proach will depend on defining an optimal dose of carvacrol
which exerts its antimicrobial effect in the host’s intestines but
does not inhibit improvement of host iron status. One challenge
in dosing is the absorption of carvacrol by the host upper GI tract,
which likely results in low concentrations in the colon and re-
duced effectiveness in this target organ. This is probably the rea-
son that oral carvacrol administration was previously shown to
have little effect on colonic microbiota composition in piglets
(23). Nevertheless, gastrointestinal health in these piglets was im-
proved, which could, for instance, relate to a reduction in viru-
lence of low-abundance gut pathogens, whereas other modes of
carvacrol delivery, e.g., in encapsulated form, still need to be ex-
amined (23). Importantly, the latter approach could be used for
the targeted delivery of antimicrobial activity in the human colon
during oral iron administration with minimal effect on iron up-
take in the ileum of the host. Subinhibitory concentrations of
carvacrol are nevertheless likely to occur in the colon. Nonethe-
less, subinhibitory concentrations are effective in reducing bacte-
rial virulence, as we show in the present study and which is sup-
ported by previous findings (9, 24). Under the experimental
culture conditions of our study, a concentration of carvacrol of
0.2 mmol/liter was already effective in reducing iron-induced
adhesion, while concentrations of0.3 mmol/liter were well tol-
erated by the differentiated intestinal epithelial cell line Caco-2.
The latter is supported by previous findings (25), and previous in
vivo studies have shown that carvacrol as a feed additive is well
tolerated and does not show signs of great cytotoxicity (23, 26).
Another challenge is to simultaneously find the optimal iron prep-
aration and dose for effective improvement of host iron status,
with minimal effect on the gut microbiota. Although we did not
test the effect of iron-carrying substances other than ferric citrate
on bacterial virulence, we believe that most soluble iron sources
will enhance the virulence of intestinal pathogens, as we previ-
ously showed for ferric citrate (3). Taken together, carvacrol is a
known natural dietary additive, with the potential to prevent gas-
trointestinal side effects during oral iron therapy in regions where
infection is endemic. Nevertheless, it goes without saying that fu-
ture in vivo studies are required to further evaluate the real thera-
peutic utility of carvacrol as an anti-infective agent in combina-
tion with dietary iron supplements.
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